Related Experiment Video
Updated: Feb 19, 2026

11:13
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
9.3K
A novel CD112-derived peptide targeting gut-primed neutrophils to attenuate deadly hepatic injury
Takayuki Kato1, Atsushi Murao1, Alok Jha1
1Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, 350 Community Dr, Manhasset, New York, 11030, USA.
Molecular Medicine (Cambridge, Mass.)
|February 17, 2026
Abstract
No abstract available in PubMed .

